Perelman School of Medicine

A study led by investigators from Massachusetts General Hospital and the Perelman School of Medicine at the University of Pennsylvania  has identified a potential target for therapies to treat cocaine addiction.

University of Pennsylvania President Amy Gutmann and David L. Cohen, chair of Penn’s Board of Trustees, invite Penn students, faculty, staff, alumni, trustees and friends, as well as the region’s business and tech community, to a series of events from 12:30 to 4:30 p.m. on Friday, Oct.

Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene -- a two-dimensional form of carbon only one atom thick -- to fabricate a

Blue light can both set the mood and set in motion important biological responses.

Robert Aronowitz, a physician and historian at the University of Pennsylvania, has been elected to membership in the Institute of Medicine, one of the nation's highest honors in the health-care field.

Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania.

The Field Center for Children’s Policy, Practice & Research at the University of Pennsylvania will host its fourth annual Field of Dreams Luncheon, Friday, Oct. 24, at the College of Physicians, 19 S. 22nd St., Philadelphia.

A first-of-its-kind set of questions included in the Internal Medicine In-Training Examination (IM-ITE) illustrates the need to better evaluate resident proficiency in high-value care (HVC), according to a new study published in Annals of Internal Medicine.

A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, and Paris. 

The University of Pennsylvania’s Basser Research Center for BRCA has announced $6.9 million to research teams both at Penn and at five other institutions across the United States, aimed at advancing the care of patients living with BRCA1 and BRCA2 mutations through multi-disciplinary collaboration.